Fate Therapeutics
FATE
FATE
157 hedge funds and large institutions have $166M invested in Fate Therapeutics in 2024 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 45 increasing their positions, 47 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
15% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 40
59% less capital invested
Capital invested by funds: $401M → $166M (-$235M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
157
Holding in Top 10
–
Calls
$91K
Puts
$39K
Top Buyers
| 1 | +$5.03M | |
| 2 | +$1.91M | |
| 3 | +$1.68M | |
| 4 |
VPC
Vestal Point Capital
New York
|
+$1.29M |
| 5 |
Citigroup
New York
|
+$1.17M |
Top Sellers
| 1 | -$19.5M | |
| 2 | -$4.99M | |
| 3 | -$3.4M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$3.04M |
| 5 |
D.E. Shaw & Co
New York
|
-$3.04M |